1. Analyst View

2. Research Methodology

3. Diagnostic Market Outlook to 2012
3.1 By Diagnosis Techniques
3.1.1 Biochemical Testing Market
3.1.2 Hematology Market
3.1.3 Immunology
3.1.4 Microbiology
3.1.5 Coagulation
3.1.6 Critical Care
3.1.7 Urinalysis

4. Diseases Prevalence Analysis

5. Cost Analysis
5.1 Affordability Factor
5.2 Health Insurance

6. Current Use of Diagnostic in India

7. Market Analysis
7.1 What Kind of Tests are Needed?
7.2 What Needs to be Tested?

8. Regulatory Environment

9. Key Players
9.1 SRL Ranbaxy
9.2 Dr. Lal PathLabs
9.3 Thyrocare Technologies Limited
9.4 Metropolis Health Services

List of Figures:

Figure 3-1: Pathology Lab Market (Billion INR), 2007-2012
Figure 3-2: Pathology Lab Market by Segment (%), 2009
Figure 3-3: Forecast for Pathology Lab Market by Segment (%), 2012
Figure 4-1: Number of Estimated Cases of Coronary Heart Disease (Million), 2005 & 2015
Figure 4-2: Number of Estimated Cases of Diabetes (Million), 2007 & 2015
Figure 4-3: New and Total Number of Cancer Patients (‘000)
Figure 5-1: Health Insurance Premium (Billion INR), 2006-07 to 2008-09